diaziquone has been researched along with Benign Meningeal Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Balis, FM; Berg, SL; Doherty, K; Gillespie, A; Holcenberg, J; Murphy, RF; Reaman, G; Sato, J; Steinherz, P; Zimm, S | 1 |
Balis, FM; Blaney, SM; Poplack, DG | 1 |
1 trial(s) available for diaziquone and Benign Meningeal Neoplasms
Article | Year |
---|---|
Phase I/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Female; Humans; Injections, Spinal; Male; Meningeal Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1992 |
1 other study(ies) available for diaziquone and Benign Meningeal Neoplasms
Article | Year |
---|---|
Pharmacologic approaches to the treatment of meningeal malignancy.
Topics: Adolescent; Adult; Antineoplastic Agents; Aziridines; Benzoquinones; Blood-Brain Barrier; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Humans; Infant; Infant, Newborn; Leukemia; Meningeal Neoplasms; Mercaptopurine; Methotrexate; Thiotepa | 1991 |